ANKRD1 and squamous cell lung carcinoma: In accordance, both in lung adenocarcinoma (LUAD) and in lung squamous cell carcinoma (LUSC) patients, the EZH2 mRNA has a negative correlation with CTGF, ANKRD1 and CYR61 transcripts (Fig. 3E).